Funded Tech Companies

SynDevRx

Wondering who invested in SynDevRx? Private investors joined the equity holders in this biopharmaceutical company.

Company Overview

Company Name
SynDevRx
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
One Broadway 14th Floor
Cambridge, MA 02142
USA
Email Address

Company Background Information

Overview
Our mission is to improve human health by developing polymeric prodrugs which deliver MetAP2 inhibitors to diseased tissues. The first two drug candidates we are developing have been previously shown to shrink tumors, inhibit angiogenesis and prevent metastasis in early clinical trials.
Profile
SynDevRx LinkedIn Company Profile
Social Media
SynDevRx Company Twitter Account
Company News
SynDevRx News
Facebook
SynDevRx on Facebook
YouTube
SynDevRx on YouTube
Last Transaction
8/16/2017

Financing History

Date
Type
Amount
Debt
$500,000
Venture Equity
$1,000,000
Debt
$1,103,575
Debt
$9,093,899
Debt
$602,747
Debt
$1,610,000
Venture Equity
$1,295,000
Venture Equity
$570,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Bradley Carver
  Bradley Carver LinkedIn Profile  Bradley Carver Twitter Account  Bradley Carver News  Bradley Carver on Facebook
VP - Bus. Development
James Shanahan
  James Shanahan LinkedIn Profile  James Shanahan Twitter Account  James Shanahan News  James Shanahan on Facebook


Company Investors

     

     

     

    Browse more funded tech companies:

    Syndero | Syndexa Pharmaceuticals

     

    Share this article

     


    About Our Venture Capital Database

    This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

     


    Additional Resources for Entrepreneurs

    Lists of Venture Capital and Private Equity Firms

    Franchise Opportunities

    Contributors

    Business Glossary